The S&P 500 rose 0.4% in afternoon trading and was on track to squeak past its all-time high set a couple weeks ago. The Dow Jones Industrial Average lost 49 points, or 0.1%, from its own record set the day before, while the Nasdaq composite was 0.6% higher, as of 1:04 p.m. Eastern time. Stock markets abroad were down, but mostly only modestly, after President-elect Trump said he plans to impose sweeping new tariffs on Mexico, Canada and China as soon as he takes office. Stock indexes were down 0.1% in Shanghai and nearly flat in Hong Kong, while Canada's main index was down 0.2%. Trump has often praised the use of tariffs, but investors are weighing whether his latest threat will actually become policy or is just an opening point for negotiations. For now, the market seems to be taking it more as the latter. Unless the United States can prepare alternatives for the autos, energy products and other goods that come from Mexico, Canada and China, such tariffs would raise the price of imported items all at once and make households poorer, according to Carl Weinberg and Rubeela Farooqi, economists at High Frequency Economics. They would also hurt profit margins for U.S. companies, while raising the threat of retaliatory tariffs by other countries. General Motors sank 8.3%, and Ford Motor fell 2.2%. Constellation Brands, which sells Modelo and other Mexican beers in the United States, dropped 3.8%. Beyond the pain such tariffs would cause U.S. households and businesses, they could also push the Federal Reserve to slow or even halt its cuts to interest rates. The Fed had just begun cutting its main interest rate from a two-decade high a couple months ago to offer support to the job market . While lower interest rates can boost the overall economy and prices for investments, they can also offer more fuel for inflation. Unlike tariffs in Trump's first term, his proposal from Monday night would affect products across the board. Trump’s tariff talk came almost immediately after U.S. stocks rose Monday amid excitement about his pick for Treasury secretary, Scott Bessent. The hope was the hedge-fund manager could steer Trump away from policies that balloon the U.S. government deficit, which is how much more it spends than it takes in through taxes and other revenue. The talk about tariffs overshadowed another set of mixed profit reports from U.S. retailers that answered few questions about how much more shoppers can keep spending. They’ll need to stay resilient after helping the economy avoid a recession, despite the high interest rates instituted by the Fed to get inflation under control. Kohl’s tumbled 16.6% after its results for the latest quarter fell short of analysts’ expectations. CEO Tom Kingsbury said sales remain soft for apparel and footwear, which helped drag its revenue lower. Kingsbury said a day earlier that he plans to step down as CEO in January. Ashley Buchanan, CEO of Michaels and a retail veteran, will replace him. Best Buy fell 6.9% after likewise falling short of analysts’ expectations. Dick’s Sporting Goods topped forecasts for the latest quarter thanks to a strong back-to-school season, but its stock lost an early gain to fall 0.3%. A report on Tuesday from the Conference Board said confidence among U.S. consumers improved in November, but not by as much as economists expected. J.M. Smucker jumped 4.6% for one of the biggest gains in the S&P 500 after topping analysts' expectations for the latest quarter. CEO Mark Smucker credited strength for its Uncrustables, Meow Mix, Café Bustelo and Jif brands. Big Tech stocks also helped prop up U.S. indexes. Gains of 2.4% for Amazon and 1.9% for Microsoft were two of the strongest forces lifting the S&P 500. In the bond market, Treasury yields rose following their big drop from a day before driven by relief following Trump’s pick for Treasury secretary. The yield on the 10-year Treasury climbed to 4.31% from 4.28% late Monday, but it’s still well below the 4.41% level where it ended last week. In the crypto market, bitcoin continued to pull back after topping $99,000 for the first time late last week. It's since dipped back toward $93,500, according to CoinDesk. It’s a sharp turnaround from the bonanza that had earlier taken over the crypto market following Trump’s election. That boom had also appeared to have spilled over into some corners of the stock market. Strategists at Barclays Capital pointed to stocks of unprofitable companies, along with other areas that can be caught up in bursts of optimism by smaller-pocketed “retail” investors. AP Business Writer Elaine Kurtenbach contributed.
JERUSALEM (AP) — Israel unleashed its largest wave of airstrikes across Lebanon since agreeing to a ceasefire with Hezbollah last week, killing at least 11 people on Monday after the Lebanese militant group fired a volley of projectiles as a warning over what it said were Israeli truce violations . The projectiles were apparently the first time that Hezbollah took aim at Israeli forces after the 60-day ceasefire went into effect last Wednesday. The increasingly fragile truce aimed to end more than a year of war between Hezbollah and Israel — part of a wider regional conflict sparked by the devastating Israel-Hamas war in Gaza . In the United States, President-elect Donald Trump demanded the immediate release of Israeli hostages held by the Palestinian militant Hamas group in Gaza, saying on social media that if they are not freed before he takes office in January there would be “HELL TO PAY.” It was not immediately clear whether Trump was threatening to directly involve the U.S. military in Israel’s ongoing war in Gaza. The U.S. has given Israel crucial military and diplomatic support throughout the nearly 15-month conflict. Lebanon’s Health Ministry said an Israeli airstrike on the southern village of Haris killed five people and wounded two while another airstrike on the village of Tallousa killed four and also wounded two. Israel's military carried out a string of airstrikes late Monday against what it said were Hezbollah fighters, infrastructure and rocket launchers across Lebanon, in response to Hezbollah firing two projectiles toward Mount Dov — a disputed Israeli-held territory known as Shebaa Farms in Lebanon where the borders of Lebanon, Syria, and Israel meet. Israel said the projectiles fell in open areas and no injuries were reported. Hezbollah said in a statement that it fired on an Israeli military position in the area as a “defensive and warning response” after what it called “repeated violations” of the ceasefire deal by Israel. It said complaints to mediators tasked with monitoring the ceasefire “were futile in stopping these violations.” Before the Hezbollah projectiles, Israeli carried out at least four airstrikes and an artillery barrage in southern Lebanon, including a drone strike that killed a person on a motorcycle, according to Lebanese state media. Another strike killed a corporal in the Lebanese security services. Israel has said its strikes are in response to unspecified Hezbollah violations, and that under the ceasefire deal it reserves the right to retaliate. Lebanon’s parliament speaker, Nabih Berri, accused Israel of violating the truce more than 50 times in recent days by launching airstrikes, demolishing homes near the border and violating Lebanon's airspace. Officials in the U.S. — which along with France helped broker the truce and heads a commission meant to monitor adherence to the deal — played down the significance of Israeli strikes. White House national security spokesman John Kirby said, “Largely speaking, the ceasefire is holding.” “We’ve gone from dozens of strikes down to one a day maybe two a day,” Kirby told reporters, referring to Israeli strikes. “We’re going to keep trying and see what we can do to get it down to zero.” Under the deal, Iran-backed Hezbollah has 60 days to withdraw its fighters and infrastructure from southern Lebanon. During that time, Israeli troops are also to withdraw to their side of the border. In a post on his Truth Social site, Trump called for Palestinian militants to free all of the roughly 100 Israeli hostages still held inside Gaza , around two-thirds of whom are believed to be alive. If not, Trump said, “Those responsible will be hit harder than anybody has been hit in the long and storied History of the United States of America. RELEASE THE HOSTAGES NOW!” Hours earlier, the Israeli government confirmed the death of Omer Neutra, a dual U.S.-Israeli citizen, whose body is still believed to be held by Hamas in Gaza, according to the Israeli government. The Biden administration is mounting a last-ditch effort to try to restart talks between Israel and Hamas. Israeli Prime Minister Benjamin Netanyahu’s office declined to comment on Trump's post though President Isaac Herzog welcomed it. In Gaza, meanwhile, alarm is mounting over increasing hunger. The amount of food allowed in by Israel has plunged over the past two months, compounded by a decision Sunday by the United Nations to halt aid deliveries from the main crossing into the territory because of the threat of armed gangs looting convoys. Experts have already warned of famine in the northernmost part of Gaza , which Israeli forces have almost completely isolated since early October, saying they're fighting regrouped Hamas militants there. Displaced families have set up tents surrounded by piles of garbage on the streets of Gaza City. Bilal Marouf, 55, said he and 11 family members fled the Israeli offensive “barefoot and naked.” “We had nothing. Hunger and thirst killed us, and we did not have a single shekel, nor clothes, nor a mattress, nor a blanket,” he said, speaking near his tent. Israel’s campaign in Gaza, triggered by Hamas’ Oct 7, 2023 attack on southern Israel, has driven almost the entire population of the territory from their homes. Hundreds of thousands of Palestinians now live in squalid tent camps, relying on international aid. The Israeli military said it allowed 40 trucks carrying 600 tons of flour for the World Food Program to enter the southern Gaza Strip on Sunday night, as well as 16 other food trucks. Israel has said it is working to increase the flow of aid. November saw an increase in the average number of humanitarian trucks it let into Gaza, up to 77 daily from 57 the month before, according to official Israeli figures. But the levels are still nearly the lowest of the entire 15-month war. And the U.N. says less than half of that actually reaches Palestinians because Israeli military restrictions, fighting and robberies make it too dangerous to deliver the aid. The World Food Program was able to only deliver aid to some 300,000 Palestinians in November across the Gaza Strip due to ongoing Israeli military offensives and the looting of convoys, Carl Skau, WFP’s deputy executive director, said Monday. In a tent camp in the central Gaza town of Deir al-Balah, Palestinians lined up at makeshift mud ovens trying to buy a few loaves of flatbread for their families. With the price of flour mounting because of scarcity, the bakers — women displaced from further north — said they could bake less bread, and families could afford far less. “They divide them to their children, one loaf every day,” said one woman baker, Wafaa al-Attar. Abou AlJoud reported from Beirut. Associated Press writer Fatma Khalid in Cairo contributed to this report. Follow AP’s war coverage at https://apnews.com/hub/mideast-warsMaverick McNealy birdies the last hole at Sea Island to finally become PGA Tour winnerBy Michelle Marchante, Miami Herald (TNS) MIAMI — As her students finished their online exam, Arlet Lara got up to make a cafe con leche . Her 16-year-old son found her on the kitchen floor. First, he called Dad in a panic. Then 911. “I had a stroke and my life made a 180-degree turn,” Lara told the Miami Herald, recalling the medical scare she experienced in May 2020 in the early months of the COVID pandemic. “The stroke affected my left side of the body,” the North Miami woman and former high school math teacher said. Lara, an avid runner and gym goer, couldn’t even walk. “It was hard,” the 50-year-old mom said. After years of rehabilitation therapy and a foot surgery, Lara can walk again. But she still struggles with moving. This summer, she became the first patient in South Florida to get an implant of a new and only FDA-approved nerve stimulation device designed to help ischemic stroke survivors regain movement in their arms and hands. This first procedure was at Jackson Memorial Hospital in Miami. Lara’s rehab was at at the Christine E. Lynn Rehabilitation Center for The Miami Project to Cure Paralysis, part of a partnership between Jackson Health System and UHealth. Every year, thousands in the United States have a stroke , with one occurring every 40 seconds, according to the U.S. Centers for Disease Control and Prevention. The majority of strokes are ischemic, often caused by blood clots that obstruct blood flow to the brain. For survivors, most of whom are left with some level of disability, the Vivistim Paired VNS System, the device implanted in Lara’s chest, could be a game changer in recovery, said Dr. Robert Starke, a UHealth neurosurgeon and interventional neuroradiologist. He also serves as co-director of endovascular neurosurgery at Jackson Memorial Hospital, part of Miami-Dade’s public hospital system. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant designed to help stroke survivors regain function in their arms, goes through exercises while her therapist activates the device during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA- approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) The Vivistim Paired VNS System is a small pacemaker-like device implanted in the upper chest and neck area. Patients can go home the same day. The U.S. Food and Drug Administration approved the stroke rehabilitation system in 2021 to be used alongside post-ischemic stroke rehabilitation therapy to treat moderate to severe mobility issues in hands and arms. Lara’s occupational therapist can activate the device during rehabilitation sessions to electrically stimulate the vagus nerve, which runs from the brain down to the abdomen and regulates various parts of the body’s nervous system. The electrical stimulation rewires the brain to improve a stroke survivor’s ability to move their arms and hands. Lara also has a magnet she can use to activate the device when she wants to practice at home. Her therapy consists of repetitive tasks, including coloring, pinching cubes and grabbing and releasing cylindrical shapes. After several weeks of rehabilitation therapy with the device, Lara has seen improvement. “Little by little, I’m noticing that my hand is getting stronger. I am already able to brush my teeth with the left hand,” she told the Miami Herald in September. Since then, Lara has finished the initial six-week Vivitism therapy program, and is continuing to use the device in her rehabilitation therapy. She continues to improve and can now eat better with her left hand and can brush her hair with less difficulty, according to her occupational therapist, Neil Batungbakal. Lara learned about the device through an online group for stroke survivors and contacted the company to inquire. She then connected them with her Jackson medical team. Now a year later, the device is available to Jackson patients. So far, four patients have received the implant at Jackson. Starke sees the device as an opportunity to help bring survivors one step closer to regaining full mobility. Strokes are a leading cause of disability worldwide. While most stroke survivors can usually recover some function through treatment and rehabilitation, they tend to hit a “major plateau” after the first six months of recovery, he said. Vivistim, when paired with rehabilitation therapy, could change that. Jackson Health said results of a clinical trial published in the peer-reviewed medical journal The Lancet in 2021 showed that the device, “when paired with high-repetition, task-specific occupational or physical therapy, helps generate two to three times more hand and arm function for stroke survivors than rehabilitation therapy alone.” The device has even shown to benefit patients 20 years from their original stroke, according to Starke. “So now a lot of these patients that had strokes 10-15 years ago that thought that they would never be able to use their arm in any sort of real functional way are now able to have a real meaningful function, which is pretty tremendous,” Starke said. Vivistim’s vagus-nerve stimulation technology was developed by researchers at the University of Texas at Dallas’ Texas Biomedical Device Center and is being sold commercially by Austin-based MicroTransponder, a company started by university graduates. Similar devices are used to treat epilepsy and depression . For Lara, the device is a new tool to help her recovery journey. “Everything becomes a challenge so we are working with small things every day because I want to get back as many functions as possible,” Lara said. Patients interested in Vivistim should speak with their doctor to check their eligibility. The FDA said patients should make sure to discuss any prior medical history, including concurrent forms of brain stimulation, current diathermy treatment, previous brain surgery, depression, respiratory diseases and disorders such as asthma, and cardiac abnormalities. “Adverse events included but were not limited to dysphonia (difficulty speaking), bruising, falling, general hoarseness, general pain, hoarseness after surgery, low mood, muscle pain, fracture, headache, rash, dizziness, throat irritation, urinary tract infection and fatigue,” the FDA said. MicroTransponder says the device is “covered by Medicare, Medicaid, and private insurance with prior authorization on a case-by-case basis.” To learn more about the device, visit vivistim.com. ©2024 Miami Herald. Visit at miamiherald.com. Distributed by Tribune Content Agency, LLC.
In Pictures: Politics frames the debate as Ireland holds five ballots in 2024Ukrainian Oligarch Firtash Among 8 Hit By Latest U.K. SanctionsTrump Brings Back Government By Social Media
It’s almost time for Spotify Wrapped. When can you expect your 2024 recap?
Is Supermicro Stock a Buy in 2025?
Tina Knowles is well aware some are popping off over Beyoncé 's Netflix Christmas Day halftime show performance ... and she's not having it. As you know, Beyoncé took the stage at the Texans-Ravens game earlier this week in her hometown of Houston ... but of course, there were some -- such as Dave Portnoy -- who bashed the show and the superstar. Momma Knowles recently took to Instagram to clap back at haters, saying in part ... "It is mind-boggling to me that you would take your precious Christmas day and watch a performance of someone you hate and you don’t think has talent so that you can go talk ish about it later😂😂." TK went on to opine that trolls were making it pretty obvious they were into Beyoncé more than they wanted to admit ... adding, "you cannot help but to watch and critique and comment and say dumb ridiculous stuff that makes you look like a joke !!" Of course, the trolls Tina's referring to had little to do with shutting down the big show -- with reports showing over 27 million people tuned in to watch the Queen blow the roof off the stadium.None
Torben Ostergaard Sells 3,022 Shares of Hippo Holdings Inc. (NYSE:HIPO) StockJaylen Brown scores 29 points before Celtics beat Timberwolves 107-105 with late defensive standPanchayat polls will be held after formalities are complete: Dy CMCommerce Bank Raises Stock Position in Delta Air Lines, Inc. (NYSE:DAL)
Sanofi (NASDAQ:SNY) Shares Acquired by Prospera Financial Services Inc
PGE CEO Patricia Poppe sells $1.15 million in stockIt’s almost time for Spotify Wrapped. When can you expect your 2024 recap?
On Tuesday, Embecta Corp EMBC posted the fourth-quarter adjusted EPS of 45 cents, beating the consensus of 36 cents and down from 59 cents reported a year ago. The company reported quarterly sales of $286.1 million, up 1.5% year over year, beating the consensus of $277 million . “We are pleased to report a strong fourth quarter and end to our fiscal year, as we once again delivered results that exceeded our expectations across key financial metrics...Additionally, the recent launch of our small-pack GLP-1 needles in Germany has gone well, and we are evaluating expanding into other markets,” said Devdatt (Dev) Kurdikar, Chief Executive Officer of Embecta. The Becton, Dickinson and Company BDX spin-off announced that it decided to discontinue its insulin patch pump program and plans to initiate a restructuring plan. In July, Embecta, a manufacturer of disposable insulin pen needles and syringes, said it is considering a potential sale following a significant drop in its share price since being spun off from health tech giant Becton, Dickinson . “We intend to concentrate our resources on our core business and to prioritize our free cash flow towards paying down debt, which we expect will give us the financial flexibility needed for future investments,” Kurdikar said. Embecta expects between $25 million and $30 million in pre-tax, cash charges for planned workforce reductions and other associated costs from the discontinuation of its patch pump program. In total, Embecta expects between $35 million and $45 million in pre-tax charges in 2025 related to its restructuring plan. It anticipates completing the restructuring in the first half of 2025. Embecta projects annual cost savings of $60 million to $65 million from this restructuring. Given the organizational restructuring plan, the company has postponed its Analyst & Investor Day to Spring 2025. Guidance: Embecta says that for the fiscal year 2025, excluding the Patch Pump program, revenues are expected to be $1.093 billion—$1.11 billion compared to a consensus of $1.12 billion, with an adjusted EPS of $2.70—$2.90 versus the consensus of $2.27. Price Action: EMBC stock is up 33.5% at $19.23 at last check Tuesday. Image via Unsplash Read Next: Why Is Exact Sciences Stock Trading Higher On Monday? © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.Rico Carty, who won the 1970 NL batting title when he hit a major league-best .366 for the Atlanta Braves, has died. He was 85. Major League Baseball , the players’ association and the Braves paid tribute to Carty on social media on Sunday. A family friend told Listín Diario — a newspaper in Carty’s native Dominican Republic — that he died Saturday night in an Atlanta hospital.
Shares of Banco Bradesco S.A. ( NYSE:BBD – Get Free Report ) gapped down prior to trading on Thursday . The stock had previously closed at $1.93, but opened at $1.89. Banco Bradesco shares last traded at $1.91, with a volume of 1,078,734 shares trading hands. Wall Street Analyst Weigh In Separately, JPMorgan Chase & Co. lowered shares of Banco Bradesco from an “overweight” rating to a “neutral” rating in a research note on Monday, November 25th. Check Out Our Latest Report on BBD Banco Bradesco Trading Down 1.0 % Banco Bradesco ( NYSE:BBD – Get Free Report ) last announced its quarterly earnings results on Thursday, October 31st. The bank reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.09 by $0.01. The company had revenue of $9.18 billion during the quarter, compared to the consensus estimate of $5.62 billion. Banco Bradesco had a return on equity of 10.17% and a net margin of 7.43%. As a group, research analysts expect that Banco Bradesco S.A. will post 0.33 EPS for the current year. Banco Bradesco Cuts Dividend The company also recently declared a — dividend, which will be paid on Monday, August 11th. Investors of record on Friday, January 3rd will be issued a dividend of $0.0362 per share. This represents a yield of 6.2%. The ex-dividend date is Friday, January 3rd. Banco Bradesco’s dividend payout ratio (DPR) is presently 11.54%. Institutional Inflows and Outflows Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Blue Trust Inc. grew its position in shares of Banco Bradesco by 99.9% during the 3rd quarter. Blue Trust Inc. now owns 11,254 shares of the bank’s stock valued at $30,000 after acquiring an additional 5,623 shares during the period. Townsquare Capital LLC purchased a new position in Banco Bradesco during the third quarter worth approximately $37,000. Insigneo Advisory Services LLC acquired a new stake in Banco Bradesco in the second quarter valued at approximately $43,000. Eagle Bay Advisors LLC increased its position in shares of Banco Bradesco by 110.5% in the third quarter. Eagle Bay Advisors LLC now owns 20,000 shares of the bank’s stock valued at $54,000 after buying an additional 10,500 shares in the last quarter. Finally, First Affirmative Financial Network acquired a new position in shares of Banco Bradesco during the 3rd quarter worth approximately $66,000. About Banco Bradesco ( Get Free Report ) Banco Bradesco SA, together with its subsidiaries, provides various banking products and services to individuals, corporates, and businesses in Brazil and internationally. The company operates through two segments, Banking and Insurance. It provides current, savings, click, and salary accounts; real estate credit, vehicle financing, payroll loans, mortgage loans, microcredit, leasing, and personal and installment credit; overdraft and agribusiness loans; debit and business cards; financial and security services; consortium products; car, personal accident, dental, travel, and life insurance; investment products; pension products; foreign currency exchange services; capitalization bonds; and internet banking services. Read More Receive News & Ratings for Banco Bradesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Banco Bradesco and related companies with MarketBeat.com's FREE daily email newsletter .Trump's team is delaying transition agreements. What does it mean for security checks and governing?
Wild first season in expanded Big 12 comes down to final weekendRico Carty, who won the 1970 NL batting title with the Atlanta Braves, dies at 85Jaylen Brown scores 29 points before Celtics beat Timberwolves 107-105 with late defensive stand
Next: lucky fortune game